BOC Sciences Grandly Promotes: One-Stop CDMO Service Platform for Drug Development
Summary
Rather, as a reputed CDMO service provider, BOC Sciences has extensively contributed to the development and production of small molecules, oligonucleotides, peptides, various chemically coupled drugs, and labeled compounds. After going through a long preparatory phase, BOC Sciences now launches a brand-new CDMO platform that integrates its years of resources, techniques, and experience.API & Intermediate Custom DevelopmentAccompanied by 20+ years of project experience, BOC Sciences has developed a one-stop R&D service package that can compete in flexibility, variety, and cost performance. "Much work has been done before we officially launch the platform, particularly the constant improvement in our facilities and techniques," the chief project manager of BOC Sciences acknowledges that they have made extra efforts to meet the demanding requirements of specialty API production. The impurity control platform assures the lowest level of impurities by adding appropriate measures during the drug process development and scale-up.Labeled Compound Custom DevelopmentAs for the labeled compound custom development, BOC Sciences also forms a set of mature operating systems. All achievements are inseparable from its multifunctional radiolabeled compound preparation platform that is equipped with the most advanced vacuum system, radioactive semi-preparative HPLC, and other instruments.With consistent technological innovation and quality assurance, BOC Sciences believes its CDMO service platform will aid researchers in opening a new chapter for their causes.